Seizure drug Qudexy XR approved for use in younger patients

Qudexy XR, a treatment option for seizures, has been approved for an expanded indication that will allow it to be used In patients as young as 2 years old, drug maker Upsher-Smith said on Monday. This treatment already had been approved for patients 10 and up since June 2014. It Is primarily used as a therapeutic measure for patients prone to partial-onset or primary generalized tonic-clonic seizures. The capsules can be ground into a fine powder and sprinkled onto soft food for patients who h Read More »

ASHP participates in effort to combat antibiotic resistance

Officials from more than 150 food companies, retailers and human and animal health stakeholders attended the recent White House Forum on Antibiotic Stewardship to make public their commitments to making changes over the next five years: to stem the development of antibiotic-resistant bacteria, find resistant strains, preserve the potency of antibiotics already in use and quell the spread of resistant infections. Read More »